A long-standing mystery surrounding a particularly aggressive childhood brain cancer, Posterior Fossa Type A (PFA) ependymoma, may finally be yielding to scientific scrutiny. Researchers have pinpointed androgens – commonly known as male hormones – as a key driver of tumor growth, offering a potential new therapeutic avenue for a disease with limited treatment options. This … Read more
Nearly 300 children in the US are diagnosed with ependymoma each year, a devastating brain tumor with a survival rate that remains stubbornly low, particularly in infants. But what if a common biological factor, present in all developing males and to a lesser extent in females, was unknowingly fueling the growth of these lethal tumors? … Read more
The harrowing journey of three-year-old Frank Cable, misdiagnosed multiple times with infections before a devastating brain tumour diagnosis, isn’t just a heartbreaking individual case. It’s a stark symptom of increasing pressures on primary care and the challenges in rapidly identifying rare conditions – challenges that are likely to intensify as healthcare systems globally grapple with … Read more
A new understanding of how “Frankengene” fusions drive rare, aggressive brain tumors in children is emerging from research at Fred Hutch Cancer Center, offering a potential pathway to targeted therapies for a disease that currently relies heavily on surgery and radiation – treatments with limited efficacy. This breakthrough isn’t just about a single tumor type; … Read more